Munaza Ijaz

Dr. Munaza Ijaz


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
Zehra EdisZehra Edis
Zehra Edis
JWJunli Wang
Junli Wang
MWMuhammad Khurram Waqas
Muhammad Khurram Waqas
MIMunaza Ijaz
Munaza Ijaz
MIMunazza Ijaz
Munazza Ijaz
Nanotechnology has been actively integrated as drug carriers over the last few years to treat various cancers. The main hurdle in the clinical management of cancer is the development of multidrug resistance against chemotherapeutic agents. To overcome the limitations of chemotherapy, the researchers have been developing technological advances for significant progress in the oncotherapy by enabling the delivery of chemotherapeutic agents at increased drug content levels to the targeted spots. Several nano-drug delivery systems designed for tumor-targeting are evaluated in preclinical and clinical trials and showed promising outcomes in cancerous tumors’ clinical management. This review describes nanocarrier’s importance in managing different types of cancers and emphasizing nanocarriers for drug delivery and cancer nanotherapeutics. It also highlights the recent advances in nanocarriers-based delivery systems, including polymeric nanocarriers, micelles, nanotubes, dendrimers, magnetic nanoparticles, solid lipid nanoparticles, and quantum dots (QDs). The nanocarrier-based composites are discussed in terms of their structure, characteristics, and therapeutic applications in oncology. To conclude, the challenges and future exploration opportunities of nanocarriers in chemotherapeutics are also presented.

5 February 2024 in Molecules
Verified
Journal Article
Open access
PDF file
Akram AshamesAkram Ashames
Akram Ashames
MIMunaza Ijaz
Munaza Ijaz
MBManal Ali Buabeid
Manal Ali Buabeid
HYHaya Yasin
Haya Yasin
SYSidra Yaseen
Sidra Yaseen
GMGhulam Murtaza
Ghulam Murtaza
Cutaneous wounds pose a significant health burden, affecting millions of individuals annually and placing strain on healthcare systems and society. Nanofilm biomaterials have emerged as promising interfaces between materials and biology, offering potential for various biomedical applications. To explore this potential, our study aimed to assess the wound healing efficacy of amniotic fluid and Moringa olifera-loaded nanoclay films by using in vivo models. Additionally, we investigated the antioxidant and antibacterial properties of these films. Using a burn wound healing model on rabbits, both infected and non-infected wounds were treated with the nanoclay films for a duration of twenty-one days on by following protocols approved by the Animal Ethics Committee. We evaluated wound contraction, proinflammatory mediators, and growth factors levels by analyzing blood samples. Histopathological changes and skin integrity were assessed through H&E staining. Statistical analysis was performed using SPSS software (version 2; Chicago, IL, USA) with significance set at p < 0.05. Our findings demonstrated a significant dose-dependent increase in wound contraction in the 2%, 4%, and 8% AMF-Me.mo treatment groups throughout the study (p < 0.001). Moreover, macroscopic analysis revealed comparable effects (p > 0.05) between the 8% AMF-Me.mo treatment group and the standard treatment. Histopathological examination confirmed the preservation of skin architecture and complete epidermal closure in both infected and non-infected wounds treated with AMF-Me.mo-loaded nanofilms. RT-PCR analysis revealed elevated concentrations of matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF), along with decreased levels of tumor necrosis factor-alpha (TNF-α) in AMF-Me.mo-loaded nanofilm treatment groups. Additionally, the antimicrobial activity of AMF-Me.mo-loaded nanofilms contributed to the decontamination of the wound site, positioning them as potential candidates for effective wound healing. However, further extensive clinical trials-based studies are necessary to confirm these findings.

16 August 2024 in Journal of Microbiology and Biotechnology
Verified
Journal Article
Open access
MIMunaza Ijaz
Munaza Ijaz
MKMadiha Khan
Madiha Khan
HYHaya Yasin
Haya Yasin
Munaza Ijaz, Madiha Khan , and Haya Yasin. J. Microbiol. Biotechnol. 2024;34:1-7. https://doi.org/10.4014/jmb.2407.07005

1 January 2025 in Green Processing and Synthesis
Verified
Journal Article
Open access
PDF file
BABadriyah Shadid Alotaibi
Badriyah Shadid Alotaibi
HYHaya Yasin
Haya Yasin
AKAbida Kalsoom Khan
Abida Kalsoom Khan
MJMizna Javed
Mizna Javed
MIMunaza Ijaz
Munaza Ijaz
Chronic wounds pose a significant healthcare challenge, necessitating innovative approaches for improved healing. Traditional medicinal plants have long been used for wound care, and recent advancements in nanotechnology offer new possibilities for enhancing their therapeutic effects. Electrospun nanofibers provide an efficient drug delivery system, improving the bioavailability and stability of bioactive compounds. This review explores the integration of phytochemical-loaded nanofibers for wound healing, highlighting their potential in treating various wounds, including burns, diabetic ulcers, and surgical wounds. Additionally, it discusses the medicinal value of traditional plants, their role in wound care, and the future prospects of combining nanotechnology with artificial intelligence for personalized treatment.